LEXINGTON, Ky. (July 8, 2020) - A grant recently received by Maj-Linda B. Selenica, assistant professor at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA), is helping further collaborative research efforts. The $125,000 grant comes from The CART Fund. CART (Coins for Alzheimer’s Research Trust) is a grassroots effort by Rotary Club members throughout the country to provide cutting edge research to help find a cure for Alzheimer’s.
Roughly one in seven Americans live with a disability that impacts daily mobility. The average cost of a wheelchair ranges from $500 to $2,000 without insurance, seriously curbing access to this essential equipment for patients who lack proper coverage. The University of Kentucky’s Center of Excellence in Rural Health (CERH) in Hazard is working to bridge this gap for Kentucky patients through a project that repairs and redistributes used medical equipment to communities in need.
A University of Kentucky College of Medicine researcher has been awarded $1.9 million to continue research examining molecular pathogenesis of Noonan-like syndrome.
Emilia Galperin, Ph.D., professor in the Department of Molecular & Cellular Biochemistry, was awarded a prestigious R35 Maximizing Investigator’s Research Award Grant from the National Institute of General Medical Sciences that will fund her lab’s research over the next five years.
Normal human cell growth is controlled by complex signaling pathways, and errors in these signal transmissions can have serious consequences inclu
In an effort to further enhance the development of our medical students’ professionalism, well-being, and social opportunities throughout their educational experience, the University of Kentucky College of Medicine Office of Medical Education has selected four faculty and staff members to serve in specialized leadership roles within student affairs, creating two new positions in the process.
Michelle Lineberry, EdD, will serve as associate dean for student affairs, which is now a 100-percent FTE position to facilitate the cohesive and seamless provision of student services.
The long-running study on aging and brain health at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) Alzheimer’s Disease Center has once again resulted in important new findings – highlighting a complex and under-recognized form of dementia. The work was recently published in The Journal of the American Medical Association (JAMA): Neurology.
“One of the things that we’ve learned in the last decade or so is that a lot of people that we think have dementia from Alzheimer’s disease, actually don’t.
Jill Blake’s diabetes journey began when she was 11 years old.
“It was 1982," she said. "I was in the 7th grade, and I began experiencing all of the classic signs and symptoms of Type 1 diabetes.”
Back then, she says the disease was not prominent in her small hometown tucked away in the hills of southeastern Kentucky. She remembers very few people in Middlesboro having knowledge of it, and she had no one in her family with diabetes.
Dr. Daniel Moore, from the University of Kentucky College of Medicine’s Department of Ophthalmology and Visual Sciences, recently conducted a study looking at the frequency and use of racial and ethnic data in ophthalmology literature published throughout 2019. He wrote an article outlining his findings which was published in The Journal of the American Medical Association: Ophthalmology.
Moore says the description of racial and ethnic data in human trials is relatively unregulated which can lead to confusion and inconsistent reporting.
Recent lab studies by chemists at the Max Planck Institute of Colloids and Interfaces (Potsdam, Germany) in close collaboration with virologists at Freie Universität Berlin have shown that extract from the medicinal plant Artemisia annua, also known as Sweet Wormwood, is active against SARS-CoV-2, the virus that has caused the COVID-19 pandemic.
The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.
The Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Program in the University of Kentucky College of Medicine is accepting applications to fill one position. Applications are due July 17, 2020.
LEXINGTON, Ky. (June 18, 2020) — Alpacas Big Boy, Blue Eyes and Emperor may hold the key to combating COVID-19. Their antibodies could offer a defense against SARS-CoV-2, the virus that causes the disease.
University of Kentucky College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected.
The University of Kentucky College of Medicine and UK HealthCare have launched a new clinical trial designed to assess the prevalence of COVID-19 in central and eastern Kentucky.
UK HealthCare's Kentucky Children's Hospital is ranked nationally in two specialties in the 2020-21 Best Children’s Hospitals rankings published online today by U.S. News & World Report, the global authority in hospital rankings and consumer advice.
KCH and Cincinnati Children’s Joint Pediatric Heart Program is ranked 14th in the country in pediatric cardiology & heart surgery.
The University of Kentucky’s six health colleges and UK HealthCare hosted a unified event on Friday afternoon to recognize racism as a public health crisis and show commitment to social justice.
Faculty, staff, and learners met in the Jacobs Science Building courtyard to stand safely in solidarity as they listened, learned, and later knelt together for 8 minutes and 46 seconds of silence to honor the memory of Black lives lost to racist violence.
Stephanie White, MD, MS, associate dean for diversity and inclusion at the College of Medicine, emceed the event.
LEXINGTON, Ky. (June 12, 2020) — In the wake of the COVID-19 pandemic, University of Kentucky experts quickly mobilized and pivoted their research to unite in the fight against the novel coronavirus.
UK researchers across many disciplines are addressing COVID-19’s medical challenges and beyond — including developing new personal protective equipment (PPE) materials, designing testing and diagnostic equipment, and examining the wider societal, economic and legal implications of the pandemic.
LEXINGTON, Ky. (June 10, 2020) – As the COVID-19 pandemic continues, researchers at the University of Kentucky are exploring the use of an antiseptic nasal spray and gargle to prevent transmission and infection of the virus among healthcare workers and non-COVID patients. The PIIPPI trial, which stands for Povidone-Iodine Intranasal for Prophylaxis in front-line Physicians/health care workers and Inpatients, is the first in the country to study iodine as a prevention measure in people who are not COVID-positive.
LEXINGTON, Ky. (June 8, 2020) – A study led by University of Kentucky Markey Cancer Center researchers showed that patients who already used opioids, sedatives or antidepressants prior to colorectal surgery experience significantly more complications post-surgery.
The COVID-19 pandemic has forced all of the University of Kentucky College of Medicine’s faculty and staff to adjust, and a major component of the adjustment has been ensuring the college’s medical education remains effective and efficient.
Much of the smooth transition can be credited to UK HealthCare Information Technology’s Academic and Research Technology (A&RT).
LEXINGTON, Ky. (June 3, 2020) – The University of Kentucky and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.
The NIH Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases, in collaboration with the Center for Clinical and Translational Sciences (CCTS) announce the availability of limited funds to support pilot projects focused on research examining obesity-associated diseases. Emphasis for support will be placed on pilot projects that examine the relationship between obesity and cardiovascular diseases, type 2 diabetes, COVID-19, cancer, or neurodegenerative diseases. These pilot grants are intended to assist investigators new to this area o
